3rd Quarter - Report

CENCORA, INC. for CENCORA, INC.

Firm
Client
Income
—
Expenses
$470,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

Implementation of the Veterinarian Food Directive; Antimicrobial Resistance.

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL Staff Assistant, U.S. Senator Elizabeth Dole (2008)
RITA E NORTON —
ASHLEY ROSE O'SULLIVAN —
BRADFORD TALLAMY —

Contacted: Centers For Medicare and Medicaid Services (CMS); White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Medicare/Medicaid MMM

H.R. 1920 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biological under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Policies to exclude cancer drugs from the sequestration cuts.

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL Staff Assistant, U.S. Senator Elizabeth Dole (2008)
RITA E NORTON —
ASHLEY ROSE O'SULLIVAN —
BRADFORD TALLAMY —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 1920 (115th)

Pharmacy PHA

S. 483 (114th Congress) legislation to prevent and reduce prescription drug abuse. H.R. 592 & S. 109, provide for coverage under Medicare program of pharmacist services. Medication Therapy Management. H.R. 1038 and S. 413, legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. Pharmaceutical compounding and the implementation of Drug Quality Security Act; FDA implementation of Section 503B of the Food, Drug, and Cosmetic Act; House & Senate Agriculture, FDA & Related Agency Appropriations bills; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017. Prescription Drug Importation including S. 771 and H.R. 1776, the Improving Access to Affordable Prescription Drugs Act and S.469, the Affordable and Safe Prescription Drug Importation Act. E-Prescribing bills including H.R. 3528 and S. 2460, the Every Prescription Conveyed Securely (EPCS) Act. H.R. 5958, Phair Pricing Act of 2018. HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. S. 3282 and H.R. 6600, the DEA Order Clearinghouse Act of 2018.

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL Staff Assistant, U.S. Senator Elizabeth Dole (2008)
RITA E NORTON —
ASHLEY ROSE O'SULLIVAN —
BRADFORD TALLAMY —

Contacted: Food & Drug Administration (FDA); White House Office; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 469 (115th), S. 2460 (115th), H.R. 5958 (115th), H.R. 1038 (115th), S. 771 (115th), S. 413 (115th), S. 483 (115th), H.R. 3528 (115th), H.R. 6600 (115th), S. 109 (115th), H.R. 592 (115th), H.R. 1776 (115th), S. 3282 (115th), H.R. 2871 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.